Autosomal dominant hypocalcemia: genes and variants

Explore variant evidence for Autosomal dominant hypocalcemia across 2 analyzed proteins (CASR, GNA11). Linked ClinVar records include 75 pathogenic or likely pathogenic variants, 1,042 variants of uncertain significance and 121 with conflicting classifications.

Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.

Data updated 2026-11-04. Automated aggregation, not a clinical review date.

Download variant evidence (CSV)

Genes linked to Autosomal dominant hypocalcemia

ClinVar pathogenic and likely pathogenic variants linked to Autosomal dominant hypocalcemia

VariantPositionProtein partClinical label
CASR G143E143Ligand-binding 1 (LB1)Pathogenic / likely pathogenic (★★)
CASR R220W220Ligand-binding 2 (LB2)Pathogenic / likely pathogenic (★★)
CASR C582S582Cysteine-rich (CR)Pathogenic / likely pathogenic (★★)
CASR F788C788TransmembranePathogenic / likely pathogenic (★★)
CASR M1T1Pathogenic / likely pathogenic (★★)
CASR R66H66Ligand-binding 1 (LB1)Pathogenic / likely pathogenic (★★)
CASR R66C66Ligand-binding 1 (LB1)Pathogenic / likely pathogenic (★★)
CASR G143R143Ligand-binding 1 (LB1)Pathogenic / likely pathogenic (★★)
CASR R220Q220Ligand-binding 2 (LB2)Pathogenic / likely pathogenic (★★)
CASR P221L221Ligand-binding 2 (LB2)Pathogenic / likely pathogenic (★★)
CASR M1V1Pathogenic / likely pathogenic (★★)
CASR R185Q185Ligand-binding 1 (LB1)Pathogenic / likely pathogenic (★★)
CASR D190G190Ligand-binding 2 (LB2)Pathogenic / likely pathogenic (★★)
CASR Y218C218Ligand-binding 2 (LB2)Pathogenic / likely pathogenic (★★)
CASR Q459R459ExtracellularPathogenic / likely pathogenic (★★)
CASR C582Y582Cysteine-rich (CR)Pathogenic / likely pathogenic (★★)
CASR R69H69Ligand-binding 1 (LB1)Pathogenic / likely pathogenic (★★)
CASR L125P125Ligand-binding 1 (LB1)Pathogenic / likely pathogenic (★★)
CASR E127A127Ligand-binding 1 (LB1)Pathogenic / likely pathogenic (★★)
CASR F128L128Ligand-binding 1 (LB1)Pathogenic / likely pathogenic (★★)
CASR R172G172Ligand-binding 1 (LB1)Pathogenic / likely pathogenic (★★)
CASR D217Y217Ligand-binding 2 (LB2)Pathogenic / likely pathogenic (★★)
CASR I555T555Cysteine-rich (CR)Pathogenic / likely pathogenic (★★)
CASR P55L55Ligand-binding 1 (LB1)Pathogenic / likely pathogenic (★★)
CASR C395R395ExtracellularPathogenic / likely pathogenic (★★)
CASR G509R509ExtracellularPathogenic / likely pathogenic (★★)
CASR E604K604Cysteine-rich (CR)Pathogenic / likely pathogenic (★★)
CASR G613E613TransmembranePathogenic / likely pathogenic (★★)
CASR G670R670ExtracellularPathogenic / likely pathogenic (★★)
CASR R680C680TransmembranePathogenic / likely pathogenic (★★)
CASR V728F728TransmembranePathogenic / likely pathogenic (★★)
CASR E767K767ExtracellularPathogenic / likely pathogenic (★★)
CASR R795W795Intracellular loop 3 (ICL3)Pathogenic / likely pathogenic (★★)
CASR P798L798Intracellular loop 3 (ICL3)Pathogenic / likely pathogenic (★★)
CASR M811V811TransmembranePathogenic / likely pathogenic (★★)
CASR F832S832ExtracellularPathogenic / likely pathogenic (★★)
GNA11 R60C60G-alphaPathogenic / likely pathogenic (★★)
CASR S53P53Ligand-binding 1 (LB1)Pathogenic / likely pathogenic (★★)
CASR T151M151Ligand-binding 1 (LB1)Pathogenic / likely pathogenic (★★)
CASR R465Q465ExtracellularPathogenic / likely pathogenic (★★)
CASR V817I817TransmembranePathogenic / likely pathogenic (★★)
CASR R886W886Interaction with RNF19APathogenic / likely pathogenic (★★)
CASR N178D178Ligand-binding 1 (LB1)Pathogenic / likely pathogenic (★★)
CASR R227Q227Ligand-binding 2 (LB2)Pathogenic / likely pathogenic (★★)
CASR N802S802Intracellular loop 3 (ICL3)Pathogenic / likely pathogenic (★★)
CASR M1R1Pathogenic / likely pathogenic (★)
CASR R220P220Ligand-binding 2 (LB2)Pathogenic / likely pathogenic (★)
CASR P221S221Ligand-binding 2 (LB2)Pathogenic / likely pathogenic (★)
CASR G549R549Cysteine-rich (CR)Pathogenic / likely pathogenic (★)
CASR C562F562Cysteine-rich (CR)Pathogenic / likely pathogenic (★)
GNA11 T54M54G-alphaPathogenic / likely pathogenic (★)
CASR R551K551Cysteine-rich (CR)Pathogenic / likely pathogenic (★)
CASR G557E557Cysteine-rich (CR)Pathogenic / likely pathogenic (★)
CASR F788L788TransmembranePathogenic / likely pathogenic (★)
CASR Y95C95Ligand-binding 1 (LB1)Pathogenic / likely pathogenic (★)
CASR E297K297Ligand-binding 2 (LB2)Pathogenic / likely pathogenic (★)
CASR I839N839TransmembranePathogenic / likely pathogenic (★)
CASR A843E843TransmembranePathogenic / likely pathogenic (★)
GNA11 R183P183G-alphaPathogenic / likely pathogenic (★)
CASR E191K191Ligand-binding 2 (LB2)Pathogenic / likely pathogenic (★)

Showing 60 of 75.

Uncertain variants prioritized for review in Autosomal dominant hypocalcemia

VariantPositionProtein partClinical labelEvidence
CASR Y218H218Ligand-binding 2 (LB2)Conflicting reports (★)+7: 7 other pathogenic changes within 3 positions; Y218C at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.891
CASR R795P795Intracellular loop 3 (ICL3)Uncertain (★)+7: 2 other pathogenic changes within 3 positions; R795W at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.916
CASR G549E549Cysteine-rich (CR)Uncertain (★)+7: 2 other pathogenic changes within 3 positions; G549R at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.911
CASR C582R582Cysteine-rich (CR)Uncertain (★)+7: 2 other pathogenic changes within 3 positions; C582Y at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.968
CASR R795Q795Intracellular loop 3 (ICL3)Uncertain (★)+7: 2 other pathogenic changes within 3 positions; R795W at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.852
CASR F788S788TransmembraneUncertain (★)+7: 2 other pathogenic changes within 3 positions; F788C at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.941
CASR P798R798Intracellular loop 3 (ICL3)Uncertain (★)+7: 2 other pathogenic changes within 3 positions; P798L at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.911
CASR G509A509ExtracellularUncertain (★)+7: G509R at the same position is pathogenic; seen in 1.4e-06 of gnomAD DNA copies; REVEL 0.932
CASR G613R613TransmembraneUncertain (★)+7: 2 other pathogenic changes within 3 positions; G613E at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.851
CASR G557W557Cysteine-rich (CR)Uncertain (★)+7: 3 other pathogenic changes within 3 positions; G557E at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.882
CASR D190N190Ligand-binding 2 (LB2)Uncertain (★)+7: 2 other pathogenic changes within 3 positions; D190G at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.819
CASR V817L817TransmembraneUncertain (★)+7: 2 other pathogenic changes within 3 positions; V817I at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.776
CASR Y218N218Ligand-binding 2 (LB2)Uncertain (★)+7: 7 other pathogenic changes within 3 positions; Y218C at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.841
CASR P55S55Ligand-binding 1 (LB1)Uncertain (★)+7: 2 other pathogenic changes within 3 positions; P55L at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.833
CASR V728L728TransmembraneUncertain (★★)+7: 2 other pathogenic changes within 3 positions; V728F at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.839
CASR R795G795Intracellular loop 3 (ICL3)Uncertain (★)+7: 2 other pathogenic changes within 3 positions; R795W at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.908
CASR R69C69Ligand-binding 1 (LB1)Uncertain (★★)+7: 3 other pathogenic changes within 3 positions; R69H at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.790
CASR D217G217Ligand-binding 2 (LB2)Uncertain (★★)+7: 5 other pathogenic changes within 3 positions; D217Y at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.804
CASR G557R557Cysteine-rich (CR)Uncertain (★)+7: 3 other pathogenic changes within 3 positions; G557E at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.805
CASR S810T810TransmembraneUncertain (★)+6: 2 other pathogenic changes within 3 positions; S810N at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.700
CASR R66L66Ligand-binding 1 (LB1)Uncertain (★★)+6: 3 other pathogenic changes within 3 positions; R66H at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.733
CASR I554F554Cysteine-rich (CR)Uncertain (★★)+6: 4 other pathogenic changes within 3 positions; I554T at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.737
CASR V728I728TransmembraneUncertain (★)+6: 2 other pathogenic changes within 3 positions; V728F at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.664
CASR P221Q221Ligand-binding 2 (LB2)Uncertain (★)+6: 6 other pathogenic changes within 3 positions; P221L at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.666

Which prediction tools work for Autosomal dominant hypocalcemia

Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.

Same protein, different disease

Diseases related to Autosomal dominant hypocalcemia

Frequently asked questions

Which genes have records linked to Autosomal dominant hypocalcemia?

This view contains 2 analyzed proteins: CASR, GNA11. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.

What do the clinical classifications mean?

Linked records include 75 pathogenic or likely pathogenic variants, 1,042 variants of uncertain significance and 121 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.

Does the evidence score change a VUS classification?

No. 24 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.

Can I download the variant evidence?

Download the CSV for all 1,260 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center